LU Kai; CHEN Tao; CHEN Yu; George F.Gao

doi:10.3967/0895-3988.2013.07.001

Transcontinental Translational Medicine Collaboration: A Successful Sino-Cuban Joint B-to-B Program

文章导航 > Biomedical and Environmental Sciences > 2013 > 26(7): 517-519

LU Kai, CHEN Tao, CHEN Yu, George F.Gao. Transcontinental Translational Medicine Collaboration: A Successful Sino-Cuban Joint B-to-B Program[J]. Biomedical and Environmental Sciences, 2013, 26(7): 517-519. doi: 10.3967/0895-3988.2013.07.001

Citation:

LU Kai, CHEN Tao, CHEN Yu, George F.Gao. Transcontinental Translational Medicine Collaboration: A Successful Sino-Cuban Joint B-to-B Program[J]. Biomedical and Environmental Sciences, 2013, 26(7): 517-519. doi: 10.3967/0895-3988.2013.07.001

doi: 10.3967/0895-3988.2013.07.001

Transcontinental Translational Medicine Collaboration: A Successful Sino-Cuban Joint B-to-B Program

Chinese Center for Disease Control and Prevention, Beijing 102206, China

摘要: Translational medicine is a comprehensive discipline that aims to convert laboratory research results into products and technology for clinical application using modern molecular biological techniques,to improve our understanding of the human body and disease and to optimize laboratory design for clinical observation and analysis for basic research.Its ultimate goal is improving holistic medicine and helping patients solve their health problems.Translational medicine includes two processes:bench to bedside and bedside to bench,known as B-to-B processes.The first B-to-B (bench to bedside) refers to the application of results of the laboratory to clinical use as a medical product or a diagnosis and treatment technology.The second B-to-B (bedside to bench) describes the process by which clinical observation and analysis provides ideas and guidance for experiment design for basic medical research.
- /
- /
- /
- /
- /
- /
- clinical observation /
- diagnosis and treatment /
- clinical application /
- research results /
- basic research /
- clinical use /
- human body

[1]	Qingxue Meng, Hongyang Yi, Peng Wang, Shan Liu, Weiquan Liang, Cuishan Chi, Chenyu Mao, Weizheng Liang, Jun Xue, Hongzhou Lu. Research Advances in the Construction and Application of Intestinal Organoids . Biomedical and Environmental Sciences, 2025, 38(2): 230-247. doi: 10.3967/bes2025.010
[2]	CAO Wei Hua, JIANG Ting Ting, SHEN Ge, DENG Wen, WANG Shi Yu, ZHANG Zi Yu, LI Xin Xin, LU Yao, ZHANG Lu, LIU Ru Yu, CHANG Min, WU Shu Ling, GAO Yuan Jiao, HAO Hong Xiao, CHEN Xiao Xue, HU Lei Ping, XU Meng Jiao, YI Wei, XIE Yao, LI Ming Hui. Association of Cytokines with Clinical Indicators in Patients with Drug-Induced Liver Injury . Biomedical and Environmental Sciences, 2024, 37(5): 494-502. doi: 10.3967/bes2024.054
[3]	National Center for Cardiovascular Diseases The Writing Committee of the Report on Cardiovascular Health and Diseases in China. Report on Cardiovascular Health and Diseases in China 2023: An Updated Summary . Biomedical and Environmental Sciences, 2024, 37(9): 949-992. doi: 10.3967/bes2024.162
[4]	LIU Yang, WANG Xin, ZHU Min, XU Ge Zhi. Clinical Characteristics of Macular Hole and Macular Epiretinal Membrane in Dominant and Nondominant Eyes . Biomedical and Environmental Sciences, 2023, 36(1): 112-116. doi: 10.3967/bes2023.014
[5]	CHEN Ai Ping, ZHANG Yong Jun. Genomic Characterization of the First Sequenced Clinical Legionella micdadei Isolate from China . Biomedical and Environmental Sciences, 2023, 36(2): 185-190. doi: 10.3967/bes2023.020
[6]	The Writing Committee of the Report on Cardiovascular Health and Diseases in China. Report on Cardiovascular Health and Diseases in China 2022: an Updated Summary . Biomedical and Environmental Sciences, 2023, 36(8): 669-701. doi: 10.3967/bes2023.106
[7]	ZHANG Lu Lu, ZHANG Chi, PENG Jun Ping. Application of Nanopore Sequencing Technology in the Clinical Diagnosis of Infectious Diseases . Biomedical and Environmental Sciences, 2022, 35(5): 381-392. doi: 10.3967/bes2022.054
[8]	The Writing Committee of the Report on Cardiovascular Health and Diseases in China. Report on Cardiovascular Health and Diseases in China 2021: An Updated Summary . Biomedical and Environmental Sciences, 2022, 35(7): 573-603. doi: 10.3967/bes2022.079
[9]	CHEN Wei, WENG Yu Wei, HE Wen Xiang, ZHU Ying, YU Ting Ting, XIE Jian Feng, ZHENG Kui Cheng, YAN Yan Sheng, ZHANG Yong Jun, ZHANG Wen Chang. RT-nPCR Assays for Amplification and Sequencing of VP1 Genes in Human Enterovirus A–D from Clinical Specimens . Biomedical and Environmental Sciences, 2020, 33(11): 829-838. doi: 10.3967/bes2020.113
[10]	WU Gui Zhen. Viral Contamination Source in Clinical Microbiology Laboratory . Biomedical and Environmental Sciences, 2016, 29(8): 609-611. doi: 10.3967/bes2016.082
[11]	ZHANG Hai Lin, CHENG Ying, WANG Xiao Jun. Breast Implant Infections:Clinical Microbiology, Early Diagnosis, and Antibiotic Treatment . Biomedical and Environmental Sciences, 2015, 28(6): 472-474. doi: 10.3967/bes2015.068
[12]	JI Xu, ZHAO Xiu Mei, JIANG Jing Jing, YIN Ling, GUO Yu Cheng. Clinical Biobanks, from the World to China . Biomedical and Environmental Sciences, 2014, 27(6): 481-483. doi: 10.3967/bes2014.079
[13]	LV Zhi Qiang, WANG Cai Hong, WANG Ting Ting, CHEN Cui Cui, WANG Ying, NING Bao An, LIU Ming, LIU Jian Qing, BAI Jia Lei, PENG Yuan, GAO Zhi Xian. Detection of Atrazine Residue in Food Samples by a Monoclonal Antibodybased Enzyme-linked Immunosorbent Assay . Biomedical and Environmental Sciences, 2013, 26(5): 398-402. doi: 10.3967/0895-3988.2013.05.010
[14]	SHI Qi, CHEN Cao, GAO Chen, TIAN Chan, ZHOU Wei, ZHANG BaoYun, HAN Jun, DONG Xiao Ping. Clinical and Familial Characteristics of Ten Chinese Patients with Fatal Family Insomnia . Biomedical and Environmental Sciences, 2012, 25(4): 471-475. doi: 10.3967/0895-3988.2012.04.013
[15]	DENG Min, WANG Yi Xiang, James F. GRIFFITH, LU Gang, Anil T AHUJA, POON Wai S. Characteristics of Rat Lumbar Vertebral Body Bone Mineral Density and Differential Segmental Responses to Sex Hormone Deficiency: a Clinical Multidetector Computed Tomography Study . Biomedical and Environmental Sciences, 2012, 25(6): 607-613. doi: 10.3967/0895-3988.2012.06.001
[16]	ZHI-GANG LIU, JUAN-JUAN SONG, XIAO-LI KONG. A Study on Pollen Allergens in China . Biomedical and Environmental Sciences, 2010, 23(4): 319-322.
[17]	DAN-HUI LIU, XIAO-MIN WANG, LI-JUAN ZHANG, SONG-WEI DAI, LI-YUN LIU, JI-FU LIU, SHAN-SHAN WU, SHUAN-YING YANG, SAM FU, XUE-YUAN XIAO, DA-CHENG HE. Serum Amyloid A Protein: A Potential Biomarker Correlated With Clinical Stage of Lung Cancer . Biomedical and Environmental Sciences, 2007, 20(1): 33-40.
[18]	QING WU, XIN-HUA ZHAO, SHENG-YUE ZHAO. Application of PCR-DGGE in Research of Bacterial Diversity in Drinking Water . Biomedical and Environmental Sciences, 2006, 19(5): 371-374.
[19]	FRANTOIS GUEYFFIERD, LI WEI, LIU Guo-zhang, ZHANG YU-QING, LIU LI-SHENG. The Effect of Antihypertensive Treatment on Cardiovascular Events——A Meta-Analysis of Four Clinical Trials in China . Biomedical and Environmental Sciences, 2001, 14(4): 341-349.
[20]	ZHOU JUN-FU, YAN XIAO-FENG, RUAN ZOU-RONG, PENG FEN-YING, CAI DONG, YUAN HONG, SUN LING, DING DE-YUN, XU SI-SUN. Heroin Abuse and Nitric Oxide, Oxidation, Peroxidation, Lipoperoxidation . Biomedical and Environmental Sciences, 2000, 13(2): 131-139.

点击查看大图

计量

文章访问数: 1298
HTML全文浏览量: 375
PDF下载量: 25
被引次数: 0

Transcontinental Translational Medicine Collaboration: A Successful Sino-Cuban Joint B-to-B Program

doi: 10.3967/0895-3988.2013.07.001

刊出日期: 2013-07-20

关键词:

clinical observation /

diagnosis and treatment /

clinical application /

摘要: Translational medicine is a comprehensive discipline that aims to convert laboratory research results into products and technology for clinical application using modern molecular biological techniques,to improve our understanding of the human body and disease and to optimize laboratory design for clinical observation and analysis for basic research.Its ultimate goal is improving holistic medicine and helping patients solve their health problems.Translational medicine includes two processes:bench to bedside and bedside to bench,known as B-to-B processes.The first B-to-B (bench to bedside) refers to the application of results of the laboratory to clinical use as a medical product or a diagnosis and treatment technology.The second B-to-B (bedside to bench) describes the process by which clinical observation and analysis provides ideas and guidance for experiment design for basic medical research.